Most of the actions of neurosteroids on the central nervous system are mediated through allosteric modulation of the ␥-aminobutyric acid type A (GABA A) receptor, but a direct effect of GABA on the regulation of neurosteroid biosynthesis has never been investigated. In the present report, we have attempted to determine whether 3␤-hydroxysteroid dehydrogenase (3␤-HSD)-containing neurons, which secrete neurosteroids in the frog hypothalamus, also express the GABAA receptor, and we have investigated the effect of GABA on neurosteroid biosynthesis by frog hypothalamic explants. Double immunohistochemical labeling revealed that most 3␤-HSD-positive neurons also contain GABAA receptor ␣3 and ␤2͞␤3 subunit-like immunoreactivities. Pulse-chase experiments showed that GABA inhibited in a dose-dependent manner the conversion of tritiated pregnenolone into radioactive steroids, including 17-hydroxy-pregnenolone, progesterone, 17-hydroxyprogesterone, dehydroepiandrosterone, and dihydrotestosterone. The effect of GABA on neurosteroid biosynthesis was mimicked by the GABA A receptor agonist muscimol but was not affected by the GABA B receptor agonist baclofen. The selective GABAA receptor antagonists bicuculline and SR95531 reversed the inhibitory effect of GABA on neurosteroid formation. The present results indicate that steroid-producing neurons of the frog hypothalamus express the GABAA receptor ␣3 and ␤2͞␤3 subunits. Our data also demonstrate that GABA, acting on GABA A receptors at the hypothalamic level, inhibits the activity of several key steroidogenic enzymes, including 3␤-HSD and cytochrome P450C17 (17␣-hydroxylase).
T
here is now clear evidence that the brain has the capability to synthesize bioactive steroids called ''neurosteroids'' (1) . Immunohistochemical and in situ hybridization studies have revealed the presence of several steroidogenic enzymes in glial cells and͞or neurons (2) . Concurrently, biochemical investigations have shown that brain explants or cultured neural cells can synthesize in vitro various regulatory steroids (3, 4) . In particular, it has been found that frog hypothalamic neurons express 3␤-hydroxysteroid dehydrogenase (3␤-HSD), a key enzyme of the steroid biosynthetic pathway, and it has been demonstrated that frog hypothalamic tissue can convert the steroid precursor pregnenolone into various bioactive metabolites, including 17-hydroxypregnenolone (17OH-⌬ 5 P), progesterone (P), 17-hydroxyprogesterone (17OH-P), dehydroepiandrosterone (DHEA), and dihydrotestosterone (5␣-DHT; refs. 5, 6) .
The effects of neurosteroids on nerve cells are modulated through several distinct categories of receptors. Neurosteroids, like other steroid hormones, can act at the transcriptional level via nuclear receptors (7) . Neurosteroids may also interact with plasma membrane G-protein-coupled receptors (8, 9) . However, most of the actions of neurosteroids appear to be mediated through ␥-aminobutyric acid type A (GABA A ) receptors (10, 11) . For instance, the effects of GABA on the GABA A receptor are allosterically modulated by progesterone and deoxycorticosterone metabolites such as allopregnanolone, pregnanolone, and tetrahydrodeoxycorticosterone (1, 11) .
Although neurosteroids are potent regulators of neuronal activities (11, 12) , little is known concerning the control of steroid biosynthesis in the brain. In particular, the possible involvement of GABA in the regulation of steroid-producing neurons has received little attention (13, 14) . In the present report, we have searched for the presence of GABA A receptors in 3␤-HSD-containing neurons in the frog hypothalamus, and we have investigated the effect of GABA on neurosteroid biosynthesis by frog hypothalamic explants.
Materials and Methods
Animals. Adult male frogs (Rana ridibunda) of about 30-40 g body weight were purchased from a commercial supplier (Couétard, Saint-Hilaire de Riez, France). The animals were maintained under artificial illumination (light on from 06:00 to 18:00) in a temperature-controlled room (8 Ϯ 0.5°C), for at least 1 week before use. Animal manipulations were performed according to the recommendations of the French ethical committee and under the supervision of authorized investigators. To limit possible variations of neurosteroid biosynthesis caused by circadian rhythms (15) , all animals were killed between 09:30 and 10:30.
Immunofluorescence Procedure. Animals were anesthetized by immersion in 0.1% 3-aminobenzoic acid ethyl ester (MS222) and perfused transcardially with 50 ml of PBS (pH 7.4). The perfusion was carried on with 50 ml of either Bouin's fixative or McLean's fixative. The brains were postfixed overnight at 4°C, embedded in Tissue Teck (Reichert-Jung), frozen at Ϫ80°C, and cut in the frontal or sagittal plane in a cryostat (6-m-thick sections). Consecutive tissue sections were incubated overnight at 4°C in a humid atmosphere with the 3␤-HSD antiserum (1:100), the polyclonal antibodies against the ␣ 3 subunit of the GABA A receptor (5 g immunoglobulins͞ml), or the monoclonal antibodies against the ␤ 2 ͞␤ 3 subunits of the GABA A receptor (10 g immunoglobulins͞ml) in PBS containing 0.3% Triton X-100 and 1% BSA. The sections were rinsed in three successive baths of PBS and then incubated for 90 min at room temperature with DAR S ͞TXR (1:50), GAM S ͞Alexa-488 (20 g͞ml), or FITC-conjugated goat anti-rabbit ␥-globulins (1:100). Other brain sections were incubated with a mixture containing the 3␤-HSD antiserum and the anti-GABA A receptor ␤ 2 ͞␤ 3 subunit immunoglobulins, and the immunoreactivity was revealed with DAR S ͞TXR and GAM S ͞Alexa-488. Finally, the sections were rinsed in PBS and mounted with PBS-glycerol (1:1).
The preparations were examined by using a confocal laser scanning microscope equipped with a diaplan optical system and an argon͞krypton ion laser (excitation wavelengths: 488͞568͞647 nm; Leica, Heidelberg, Germany). Dual-channel confocal laser scanning microscopic analysis was performed using a band-pass filter ( ϭ 535 Ϯ 7 nm) for detection of FITC or Alexa-488, and a long-pass filter ( ϭ 610 nm) for detection of TXR.
The specificity of the immunoreaction was controlled either by substituting the primary antisera with PBS or by preincubating the antibodies against 3␤-HSD with purified human type I 3␤-HSD (10 Ϫ6 M) and the antibodies against the GABA A receptor ␣ 3 subunit with the synthetic peptide hapten (16 g͞ml P into progesterone, 17OH-⌬ 5 P͞5␣-DHT, 17OH-P, and DHEA was studied using a pulse-chase technique as previously described (5) . For each exper- iment, the hypothalami of four frogs were rapidly dissected, and each hypothalamus was cut into two pieces. The tissue fragments were preincubated for 15 min in 1 ml of Ringer's solution (pH 7.4). The hypothalamic slices were incubated at 24°C for 2 h in 500 l of Ringer's medium containing 4% propylene glycol and 10
P, in the absence or presence of test substances. At the end of the incubation period, the medium was collected and kept at 4°C until extraction. The tissues were rinsed four times with ice-cold Ringer's buffer and homogenized in 750 l of trichloroacetic acid. Steroids contained in the tissue homogenates and incubation media were extracted three times in 1 ml of dichloromethane as previously described (5 Fig. 4 . Tritiated compounds eluted from the HPLC column were directly quantified with a flow scintillation analyzer (Radiomatic Flo-One\Beta A-500; Packard) equipped with a 486DX50 PC computer for measurement of the percentage of total radioactivity contained in each peak. HPLC standards, consisting of synthetic steroids, were detected by UV absorption at 240 nm, using a Gilson UV detector (model 115).
Quantification of Steroid Biosynthesis and Statistical
Analysis. The amount of radioactive steroids formed by conversion of [ 3 H]⌬ 5 P was expressed as a percentage of the total radioactivity contained in all peaks resolved by HPLC, including [ 3 H]⌬ 5 P itself. Each value is the mean of four independent experiments. Statistical analysis was performed by ANOVA, followed by a Dunnett's or a Bonferroni's multiple comparison test.
Results
Immunocytochemistry. As previously reported (5), the rabbit antibody raised against human placental type I 3␤-HSD produced intense and specific staining of several neuronal populations in the frog hypothalamus. Labeling of consecutive sections of the frog diencephalon with the antiserum against 3␤-HSD and the antiserum against the GABA A receptor ␣ 3 subunit showed that several 3␤-HSD-positive neurons also contained ␣ 3 subunitlike immunoreactivity in the anterior preoptic area ( Fig. 1 A and  B) , the dorsal and ventral hypothalamic nuclei, the nucleus of the periventricular organ, and the posterior tuberculum ( Fig. 1 C and  D) . However, in the hypothalamic nuclei, the GABA A receptor ␣ 3 subunit-immunofluorescent material was not found in all 3␤-HSD-positive neurons (Fig. 1) . Reciprocally, 3␤-HSD-like immunoreactivity was not detected in all GABA A receptor ␣ 3 subunit-positive cells (Fig. 1) .
Double labeling of brain slices with the 3␤-HSD antiserum and the monoclonal antibody against the ␤ 2 ͞␤ 3 subunits of the GABA A receptor showed that part of the 3␤-HSD-positive neurons localized in the posterior tuberculum (Fig. 2 A-C) and the nucleus of the periventricular organ (Fig. 2 D-F ) also exhibited ␤ 2 ͞␤ 3 subunit-like immunoreactivity. The occurrence of ␤ 2 ͞␤ 3 subunit-immunoreactive material in 3␤-HSD-positive neurons was also observed in the anterior preoptic area, the suprachiasmatic nucleus, and the ventral and dorsal hypothalamic nuclei (data not shown). Most neurons that expressed the ␣ 3 subunit also contained the ␤ 2 ͞␤ 3 subunit. However, a few neurons exhibited only ␣ 3 subunit-or only ␤ 2 ͞␤ 3 subunit-like immunoreactivity (data not shown).
Preincubation of the 3␤-HSD antiserum with purified human type I 3␤-HSD (10 Ϫ6 M) resulted in complete loss of the immunoreaction (Fig. 3 A and B) . Similarly, preincubation of the antiserum against the GABA A receptor ␣ 3 subunit with the synthetic peptide hapten totally abolished immunostaining (Fig.  3 C and D) . No fluorescence was observed when the primary antibodies against 3␤-HSD, ␣ 3 subunit, or ␤ 2 ͞␤ 3 subunits were replaced by PBS (data not shown).
Effect of GABA on Neurosteroid Biosynthesis. After a 2-h incubation of frog hypothalamic explants with [ 3 H]⌬ 5 P, reversed-phase HPLC analysis of the tissue homogenates and incubation media made it possible to resolve several radioactive compounds, including 17OH-⌬ 5 P, 5␣-DHT, DHEA, 17OH-P, testosterone, and P (Fig. 4 A and C) . In the presence of GABA (10 Ϫ6 M), the levels of tritiated metabolites newly synthesized from [ 3 H]⌬ 5 P were markedly attenuated in the tissue extracts (Fig. 4B ) and the incubation media (Fig. 4D) . Exposure of frog hypothalamic slices to graded concentrations of GABA (10 Ϫ8 to 10 Ϫ4 M) induced a dose-dependent decrease in the biosynthesis of 17OH-⌬ 5 P͞5␣-DHT (Fig. 5A), DHEA (Fig. 5B ), 17OH-P (Fig. 5C), and P (Fig.   5D ). Incubation of the tissue explants with GABA (10 Ϫ6 M) significantly reduced also the amount of 3 H-labeled steroids secreted into the incubation medium: 17OH-⌬ 5 P͞5␣-DHT, Ϫ45% (P Ͻ 0.05); DHEA, Ϫ25% (P Ͻ 0.05); 17OH-P, Ϫ53% (P Ͻ 0.01) and P, Ϫ35% (P Ͻ 0.05).
Effect of GABA Receptor Agonists and Antagonists on Neurosteroid
Biosynthesis. The pharmacological characteristics of the receptors involved in the action of GABA were studied using various GABA A and GABA B receptor agonists and͞or antagonists. Incubation of frog hypothalamic slices with the selective GABA A receptor agonist muscimol (10 P͞5␣-DHT, DHEA, 17OH-P, and P (Fig. 6) . In contrast, the GABA B receptor agonist baclofen (10 Ϫ5 M) did not significantly modify the level of steroid synthesis by hypothalamic explants (Fig. 6) .
The inhibitory effect of GABA on the formation of 17OH-⌬ 5 P͞5␣-DHT, DHEA, 17OH-P, and P was completely reversed by the specific GABA A receptor antagonists bicuculline (10 P͞5␣-DHT, DHEA, 17OH-P, and P (Fig. 7) .
Discussion
Most of the central effects of neurosteroids are mediated through allosteric modulation of GABA A receptors, but a direct effect of GABA on neurosteroid biosynthesis has never been demonstrated. The present study provides evidence for the expression of GABA A receptors in neurosteroid-secreting neurons. Our data also demonstrate that GABA, acting through GABA A receptors, exerts an inhibitory effect on the production of ⌬ 5 -3␤-hydroxysteroid and ⌬ 4 -3-ketosteroids in the frog hypothalamus. Among the 15 different GABA A receptor subunits that have been characterized to date (19) (20) (21) , the ␣ 1 and ␤ 2 subunits are, by far, the most common subunits occurring in native GABA A receptors in the brain (22) (23) (24) (25) . The ␣ 3 subunit is also contained in a significant proportion of GABA A receptors (22, 24, 25) . To investigate whether 3␤-HSD-containing neurons also express GABA A receptors, we have used a specific polyclonal antibody against the ␣ 3 subunit (17, 18, 26) and a monoclonal antibody against the ␤ 2 ͞␤ 3 subunits that also cross-reacts with the ␣ 1 subunit (24, 27, 28) . In a recent report, this latter antibody has been used successfully to localize the GABA A receptor complex in the brain of the frog Rana pipiens (29) . The present study reveals that most of the 3␤-HSD-positive neurons located in the anterior preoptic area, the suprachiasmatic nucleus, the posterior tuberculum, the nucleus of the periventricular organ, and the dorsal and ventral hypothalamic nuclei also contain GABA A receptor ␣ 3 and ␤ 2 ͞␤ 3 subunit-like immunoreactivity. Because recombinant GABA A receptors consisting of ␣ 1 ͞␣ 3 , ␤ 2 ͞␤ 3 , and ␥ 2 subunits are functionally activated by GABA (22, 30, 31) and exhibit high affinity for central-type benzodiazepines (28) , our data suggested that GABA could actually modulate the biosynthesis of steroids in 3␤-HSD-containing neurons. Incubation of frog hypothalamic explants with graded concentrations of GABA provoked a dose-dependent inhibition of the conversion of [ P and DHEA. These observations indicate that, in the frog brain, GABA inhibits the biological activity of at least two steroidogenic enzymes, i.e., 3␤-HSD and 17␣-hydroxylase. Consistent with this notion, in vivo studies have recently shown that depression of GABA neurotransmission by the GABA synthesis inhibitor isoniazid increases the content of ⌬ 5 P, P, and THDOC (tetrahydrodeoxycorticosterone) in the rat brain (14) . The fact that GABA also significantly inhibited the concentration of newly synthesized steroids in the incubation medium indicates that GABA simultaneously reduces biosynthesis and release of neurosteroids by hypothalamic neurons. experiments. * , P Ͻ 0.05; ** , P Ͻ 0.01; *** , P Ͻ 0.001 by one-way ANOVA followed by a post hoc Bonferroni's test; NS, not statistically different. Each value is the mean (ϮSEM) of four independent experiments. ** , P Ͻ 0.01 by one-way ANOVA followed by a post hoc Dunnett's test; NS, not statistically different vs. control.
The present report demonstrates that the action of GABA on neurosteroidogenesis is mediated through GABA A receptors: (i) The selective GABA A receptor agonist muscimol mimicked the inhibitory effect of GABA on the biosynthesis of 17OH-⌬ 5 P͞5␣-DHT, P, 17OH-P, and DHEA, whereas the GABA B receptor agonist baclofen did not affect neurosteroid synthesis. (ii) The effect of GABA was abolished by the GABA A receptor antagonists bicuculline and SR95531. We have also noticed that bicuculline and SR95531 enhanced the spontaneous production of 17OH-⌬ 5 P͞5␣-DHT, DHEA, 17OH-P, and P, suggesting that endogenous GABA, acting on GABA A receptors, actually exerts a tonic inhibitory control on hypothalamic neurons that synthesize neurosteroids. The effect of GABA on pregnenolone biosynthesis in the rat retina is also mediated through GABA A receptors, although, in this latter model, GABA exerts a stimulatory effect on steroid production (13) .
In conclusion, the present study provides evidence for the occurrence of GABA A receptors on 3␤-HSD-immunoreactive neurons in the brain of vertebrates. This report also demonstrates that GABA, acting through GABA A receptors, reduces the rate of conversion [ -3␤-hydroxysteroids. Taken together, these observations indicate that GABA exerts a direct inhibitory effect on steroidproducing neurons. Because neurosteroids are potent regulators of GABA A receptor function (10, 11, 32) , our data suggest the existence of an ultrashort regulatory loop by which neurosteroids may regulate their own production through the modulation of GABA A receptor activity.
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